Sofosbuvir Active Not Recruiting Phase 4 Trials for Hepatitis C Viral Infection / Liver Cirrhosis / Human Immunodeficiency Virus (HIV) Treatment

Active Not RecruitingTreatment4 IdentifierTitleDrugs
NCT02533934Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
NCT02304159Study to Evaluate the Safety and Efficacy of Daclatasvir/Sofosbuvir/Ribavirin for 16 Versus 24 Weeks for HCV Genotype 3 Cirrhotics